Simcere is an innovation and R&D-driven pharmaceutical company with a focus on three therapeutic areas, oncology, central nervous system and autoimmune diseases aiming to achieve the mission of "providing today's patients with medicines of the future." Leveraging its R&D capability and commercialization excellence, Simcere has built a market-leading product portfolio in China. Its vigorous in-house R&D efforts and extensive R&D and commercial stage collaborations have made it a strategic alliance partner with world-leading innovative companies and research institutes.